BARINTHUS BIOTHERAPEUTICS PL
ADS · CUSIP 91864C107
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $1.13.
Trends to Q3 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 12 |
| Q4 2022 | 16 |
| Q1 2023 | 14 |
| Q2 2023 | 16 |
| Q3 2023 | 17 |
| Q4 2023 | 16 |
| Q1 2024 | 16 |
| Q2 2024 | 19 |
| Q3 2024 | 20 |
| Q4 2024 | 17 |
| Q1 2025 | 16 |
| Q2 2025 | 15 |
| Q3 2025 | 15 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2023 | 4 | 3 |
| Q1 2024 | 2 | 2 |
| Q2 2024 | 5 | 2 |
| Q3 2024 | 5 | 4 |
| Q4 2024 | 2 | 7 |
| Q1 2025 | 5 | 7 |
| Q2 2025 | 3 | 3 |
| Q3 2025 | 6 | 4 |
Biggest buyers
| RENAISSANCE TECHNOLOGIES LLC | Added | +30.0k |
| HRT FINANCIAL LP | New | +20.2k |
| XTX Topco Ltd | New | +13.0k |
| MORGAN STANLEY | Added | +90 |
| UBS Group AG | New | +13 |
| SBI Securities Co., Ltd. | New | +1 |
Biggest sellers
| GILEAD SCIENCES, INC. | Sold out | -99.5k |
| Baird Financial Group, Inc. | Reduced | -85.0k |
| CITADEL ADVISORS LLC | Sold out | -16.2k |
| New England Capital Financial Advisors LLC | Sold out | -45 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Cawood Frank Wayne 13G · passive investor filed 2025-02-11 | 8.4% |
International Generosity Foundation Trust
13D · may seek influence
new · filed 2026-04-13
Stated purposeThe Reporting Person acquired the securities for investment purposes and in connection with its charitable activities. The Reporting Person may, from time to time, sell or otherwise dispose of some or all of the securities, including to support its charitable purposes, or acquire additional securities, depending on market conditions and other factors. Except as set forth above, the Reporting Person has no present plans or proposals that relate to or would result in any of the actions described in Items 4(a) through (j) of Schedule 13D. Full filing |
6.7% |
Fell to 5% or below in the last year: Oxford Science Enterprises plc (0.0%, 2026-09-11)
Holders, Q3 2025
| Manager | Shares | Change |
|---|---|---|
| M&G PLC 0.03% of their portfolio | 5.2m $5.2m | Unchanged |
| Alphabet Inc. 0.08% of their portfolio | 1.5m $1.9m | Unchanged |
| HSG Holding Ltd 0.10% of their portfolio | 1.4m $2.0m | Unchanged |
| DC Funds, LP 25.81% of their portfolio | 642.2k $802.8k | Unchanged |
| Johns Hopkins University 0.01% of their portfolio | 122.2k $152.8k | Unchanged |
| Baird Financial Group, Inc. 0.00% of their portfolio | 107.5k $134.3k | Reduced -85.0k |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 66.3k $82.9k | Added +30.0k |
| HighTower Advisors, LLC 0.00% of their portfolio | 37.5k $46.8k | Unchanged |
| HRT FINANCIAL LP 0.00% of their portfolio | 20.2k $25.0k | New |
| Janney Montgomery Scott LLC 0.00% of their portfolio | 15.4k $19.0k | Unchanged |
| XTX Topco Ltd 0.00% of their portfolio | 13.0k $16.3k | New |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 11.6k $14.5k | Unchanged |
| MORGAN STANLEY 0.00% of their portfolio | 4.9k $6.2k | Added +90 |
| UBS Group AG 0.00% of their portfolio | 13 $16 | New |
| SBI Securities Co., Ltd. 0.00% of their portfolio | 1 $1 | New |